Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single‐Use Autoinjector: A Phase II Study

Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single‐Use Autoinjector: A Phase II Study

Introduction: Hypogonadism is one of the most common male endocrine problems. Although many treatments are currently available, unmet need exists for new testosterone (T) replacement therapies that are simple to administer and use, are safe, and mimic physiologic T levels. Aim: The study aim was to...

Full description

Bibliographic Details
Main Authors: Jed Kaminetsky, MD, Jonathan S. Jaffe, MD, Ronald S. Swerdloff, MD
Format: Article
Language:English
Published: Oxford University Press 2015-12-01
Series:Sexual Medicine
Subjects:
Subcutaneous Injection
Testosterone
Autoinjector
Viscosity
Hypogonadism
Male
Clinical Trial
Phase II
Online Access:http://www.sciencedirect.com/science/article/pii/S2050116116300058

Internet

http://www.sciencedirect.com/science/article/pii/S2050116116300058

Similar Items